Treatment for suspected gonorrhea is:

Rationale: A. Penicillin G is no longer a recommended treatment for gonorrhea due to the widespread development of penicillinase-producing Neisseria gonorrhoeae strains. Using this agent would likely result in treatment failure and the continued spread of the infection. It remains the drug of choice for syphilis but has lost its clinical utility against most modern gonococcal infections. B. Doxycycline is often used as a co-treatment to cover potential Chlamydia trachomatis infection, but it is not recommended as monotherapy for gonorrhea. The pathogen has demonstrated increasing resistance to tetracyclines, making them unreliable for eradicating the primary infection. Current guidelines emphasize that doxycycline should only be used as an adjunct to a more potent antigonococcal agent. C. Ciprofloxacin and other fluoroquinolones were once standard treatments, but they are no longer recommended by the CDC due to high levels of global resistance. Using ciprofloxacin for gonorrhea today carries a high risk of clinical failure. Antimicrobial stewardship requires moving away from this class for gonorrhea to prevent further resistance and ensure effective eradication of the bacteria. D. Ceftriaxone is a third-generation cephalosporin and is currently the first-line, gold-standard treatment for uncomplicated gonococcal infections. It is typically administered as a single intramuscular dose to ensure compliance and provide high bactericidal concentrations. Its efficacy against Neisseria gonorrhoeae remains high, making it the most reliable pharmacological intervention in modern clinical practice for this sexually transmitted infection.